Ctt Pharmaceutical Holdings Stock Investor Sentiment

CTTH Stock  USD 0.08  0.01  9.37%   
Under 61% of CTT Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading CTT Pharmaceutical Holdings pink sheet suggests that many investors are alarmed at this time. CTT Pharmaceutical's investing sentiment shows overall attitude of investors towards CTT Pharmaceutical Holdings.
  
few days ago at news.google.com         
Nicotine Strip Breakthrough CTT Pharma Makes Elite Cut in 175K NSF Grant Competition - StockTitan
Google News at Macroaxis
over a week ago at news.google.com         
Ctt pharmaceutical holdings CEO acquires shares worth 624 - MSN
Google News at Macroaxis
over a week ago at news.google.com         
Ctt pharmaceutical holdings CEO acquires shares worth 624 - MSN
Google News at Macroaxis
over a week ago at news.google.com         
Cancer Research Pioneer with NIH Background Joins CTT Pharmaceuticals Board - StockTitan
Google News at Macroaxis
over a week ago at news.google.com         
Major Share Structure Overhaul CTT Pharma Cuts 150M Authorized Shares, Eyes Exchange Upgrade - Stock...
Google News at Macroaxis
over two weeks ago at news.google.com         
CTT Pharma submits proposal for NIH grant - MSN
Google News at Macroaxis
over two weeks ago at news.google.com         
This Biotechs New Nicotine Strip Could Change How Millions Quit Smoking - StockTitan
Google News at Macroaxis
over two weeks ago at news.google.com         
Game-Changing Nicotine Strip Could Help Millions Quit Smoking in Seconds, Not Hours - StockTitan
Google News at Macroaxis
over three weeks ago at news.google.com         
CTT Pharma Has Engaged the OTC Markets to Uplist to the OTCQB - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
High Hampton Holdings Corp. Appoints Cam Birge as Independent Director - Marketscreener.com
Google News at Macroaxis
over two months ago at news.google.com         
Ctt pharmaceutical holdings CEO acquires 1,400 in shares - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
ASX Winners And Losers Of Today 18-10-24 - FN Arena News
Google News at Macroaxis
over three months ago at news.google.com         
CTT Pharmaceutical Holdings CEO acquires shares worth 41 - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
CTT Pharmaceutical Holdings CEO acquires shares worth 60 - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
CTT Pharmaceutical Holdings CEO acquires 145 in company stock - Investing.com India
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about CTT Pharmaceutical that are available to investors today. That information is available publicly through CTT media outlets and privately through word of mouth or via CTT internal channels. However, regardless of the origin, that massive amount of CTT data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of CTT Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CTT Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CTT Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CTT Pharmaceutical alpha.

CTT Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for CTT Pink Sheet analysis

When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm